← Leaderboards
Omar Galarraga
University Of California Berkeley
$6,454,943
Attributed
$11,525,963
Total exposure
9
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,525,963 · 9
By mechanism
R01$9,150,193 · 3
R21$1,227,560 · 3
R34$637,987 · 1
K01$347,723 · 1
R03$162,500 · 1
Top collaborators
- Theresa I. Shireman7 shared
- David M Williams7 shared
- Becky Lynn Genberg5 shared
- Philip Andrew Chan2 shared
- Jacqueline Hoare2 shared
Most similar at University Of California Berkeley
Same institution · by research overlap
- Ronald D Lee$15,560,657
- Sylvia Guendelman$386,323
Others in their field
Top investigators on “Programs”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,641,009,751
- Leonard Freedman · Leidos Biomedical Research, Inc.$994,984,644
- Lawrence Corey · Fred Hutchinson Cancer Center$730,186,538
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$609,313,548
Research focus
ProgramsCostFutureAffectBaseInnovationTransmission ProcessLow IncomePersonsAdherenceIncentivesBehaviorMedication CompliancePrevalenceEconomicsEnsureHealth EconomicsPreventionFundingCaringPoliciesCommunitiesFaceAntiretroviral Therapy
Grant awards (33)
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial$683,810
R01 · FY2025 · CA
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$647,971
R01 · FY2024 · MH
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial$633,063
R01 · FY2024 · CA
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$673,733
R01 · FY2023 · MH
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$506,812
R01 · FY2023 · MH · contact PI
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial$58,310
R01 · FY2023 · CA
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$703,782
R01 · FY2022 · MH
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial$655,875
R01 · FY2022 · CA
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$533,750
R01 · FY2022 · MH · contact PI
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$752,850
R01 · FY2021 · MH
Empirical testing of a widely available insurance-based monetary incentive program for exercise: A randomized trial$683,723
R01 · FY2021 · CA
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$541,608
R01 · FY2021 · MH · contact PI
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$100,025
R01 · FY2021 · MH
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$94,466
R01 · FY2021 · MH
Impact of Prescription Caps on Health Outcomes in People Infected with HIV$706,557
R01 · FY2020 · MH
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$556,494
R01 · FY2020 · MH · contact PI
Harambee: Integrated Community-Based HIV/NCD Care & Microfinance Groups in Kenya$617,364
R01 · FY2019 · MH · contact PI
PrEP Seguro: Antiretrovial-based HIV prevention among men at high risk in Mexico$140,778
R34 · FY2019 · MH · contact PI
PrEP Seguro: Antiretrovial-based HIV prevention among men at high risk in Mexico$242,279
R34 · FY2018 · MH · contact PI
Evaluating HIV pre-exposure prophylaxis implementation using an all payers claims database$225,422
R21 · FY2018 · MH
PrEP Seguro: Antiretrovial-based HIV prevention among men at high risk in Mexico$254,930
R34 · FY2017 · MH · contact PI
Conditional Economic Incentives for Improving Adolescent Adherence to HIV Treatment$216,477
R21 · FY2017 · AI · contact PI
Evaluating HIV pre-exposure prophylaxis implementation using an all payers claims database$200,264
R21 · FY2017 · MH
Conditional Economic Incentives for Improving Adolescent Adherence to HIV Treatment$187,184
R21 · FY2016 · AI · contact PI
Using Behavioral Economics to Promote Exercise among Inactive Overweight Adults$81,250
R03 · FY2016 · CA
Using Behavioral Economics to Promote Exercise among Inactive Overweight Adults$81,250
R03 · FY2015 · CA
Conditional Economic Incentives to Reduce HIV Risks: A Pilot in Mexico$193,096
R21 · FY2012 · HD · contact PI
Conditional Economic Incentives to Reduce HIV Risks: A Pilot in Mexico$25,481
R21 · FY2012 · HD · contact PI
Conditional Economic Incentives to Reduce HIV Risks: A Pilot in Mexico$179,636
R21 · FY2011 · HD · contact PI
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico$55,822
K01 · FY2010 · TW · contact PI
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico$53,419
K01 · FY2010 · TW · contact PI
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico$119,241
K01 · FY2009 · TW · contact PI
Conditional Cash Transfers to Prevent Sexually Transmitted Infections in Mexico$119,241
K01 · FY2008 · TW · contact PI